Sutton Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25
Closed -$1.01K 868
2023
Q1
$1.01K Hold
25
﹤0.01% 729
2022
Q4
$1.12K Buy
25
+22
+733% +$996 ﹤0.01% 1293
2022
Q3
$144 Buy
+3
New +$164 ﹤0.01% 1573
2022
Q2
Sell
-2
Closed -$233 1716
2022
Q1
$233 Sell
2
-5
-71% -$584 ﹤0.01% 1560
2021
Q4
$1.05K Buy
+7
New +$945 ﹤0.01% 1317

Other funds holding TNDM

Sutton Wealth Advisors's TNDM Position: Q2 2023 in Review

Sutton Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 25 shares — an estimated $1.01K sold.

Sutton Wealth Advisors first reported a position in TNDM in Q4 2021 and held it in 5 quarters. The position peaked at $1.12K in Q4 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Sutton Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 25 Tandem Diabetes Care shares in Q2 2023, an estimated $1.01K.
  • Sutton Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 5 quarters.
  • Sutton Wealth Advisors's Tandem Diabetes Care position peaked at $1.12K in Q4 2022.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Sutton Wealth Advisors's 13F filing for Q2 2023, filed 8 Nov 2023.